3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Conditions
Motor Activity
4
Breast Neoplasms
4
Head and Neck Neoplasms
2
Fatigue
2
Uterine Cervical Neoplasms
1
Trismus
1
Sarcoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Lymphedema
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Brain Neoplasms
1
Agnosia
1
Interventions
Doxorubicin
19
Radiotherapy
10
Ifosfamide
10
apatinib
9
anlotinib
8
Cyclophosphamide
8
camrelizumab
7
Vincristine
5
Dactinomycin
5
toripalimab
3
Trabectedin
3
Radiation Dose Hypofractionation
3
Etoposide
3
Docetaxel
3
ribociclib
2
brostallicin
2
Topotecan
2
Thalidomide
2
Temozolomide
2
Sorafenib
2
Oncolytic Virotherapy
2
Nivolumab
2
Neoadjuvant Therapy
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Gene Expression Profiling
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Sarcoma
×
Exercise Therapy
×
Clear all
NCT04517019
2020-08-18
OnkoFit II
University Hospital Tuebingen
Phase NA
Unknown
201 enrolled